Tao Lu

3.1k citations

116 papers · 2.4k indexed · h-index 25

Hematology top 5%
- Acute Myeloid Leukemia Research 9
Aging top 10%
Oncology top 10%
- Cancer-related Molecular Pathways 10
Molecular Biology top 10%
- Protein Degradation and Inhibitors 10
- Histone Deacetylase Inhibitors Research 6
Cancer Research top 10%
Computational Theory and Mathematics
- Computational Drug Discovery Methods 20
Organic Chemistry
- Synthesis and biological activity 6
Genetics
- Chronic Lymphocytic Leukemia Research 6
Hepatology
- Liver physiology and pathology 5

Co-authors: Yadong Chen Xuanyong Liu Congqin Ning Paul K. Chu Hongmei Li Shuai Lü Honglu Wu Jin Wen
Cited by: Hematology Aging Oncology
Partner nations: China United States United Kingdom

In The Last Decade

Tao Lu

111 papers receiving 2.4k citations

Peers

Countries citing papers authored by Tao Lu

Since Specialization

Citations

This map shows the geographic impact of Tao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Lu more than expected).

Fields of papers citing papers by Tao Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Lu. The network helps show where Tao Lu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Tao Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tao Lu Line = papers co-authored together Tao Lu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A novel detection mode for ascorbic acid with high selectivity based on peroxidase mimetic system Wen‐Fei Dong,Jie Liu,Hongmei Lan,Tao Lu,Yi Liu,Zhentao Ran,Z Wang,Haiyan Cao,Wenbing Shi,Guo Chen	2025	1
2	Therapeutic potential of luteolin in central precocious puberty: insights from a danazol-induced rat model Zhijian Zha,Enze Lei,Xiaofan Wu,Shanshan Bai,Tiantian Huang,Tao Lu,Zifeng Wang,Yan Cai,Hui Li,Yao Chen,Jianzhong Liu	2025	0
3	Design, Synthesis, and Biological Evaluation of a Novel NIK Inhibitor with Anti-Inflammatory and Hepatoprotective Effects for Sepsis Treatment Nanxia Zhang,Shige Shen,Mengyu Yang,Sijie He,Chunxiao Liu,Hongmei Li,Tao Lu,Haichun Liu,Qinghua Hu,Weifang Tang,Yadong Chen	2024	7
4	ScribSD+: Scribble-supervised medical image segmentation based on simultaneous multi-scale knowledge distillation and class-wise contrastive regularization Yijie Qu,Tao Lu,Shaoting Zhang,Guotai Wang	2024	2
5	A naturally derived small molecule compound suppresses tumor growth and metastasis in mice by relieving p53-dependent repression of CDK2/Rb signaling and the Snail-driven EMT Bo‐Xue Ren,Yang Li,Lei Di,Ranran CHENG,Li‐Juan Liu,Hongmei Li,Yi Li,Zhang‐Rui Tang,Yong‐Ming Yan,Tao Lu,Rong Fu,Yong‐Xian Cheng,Zhao‐Qiu Wu	2024	2
6	Discovery of 3-(1H-benzo[d]imidazole-2-yl)-1H-pyrazol-4 -amine derivatives as novel and potent syk inhibitors for the treatment of hematological malignancies Bingbing Cui,Yong Wang,Zhipeng Zhao,Fan Lü,Yu Jiao,Hongmei Li,Jie Feng,Weifang Tang,Tao Lu,Yadong Chen	2023	7
7	The effect of cerebral blood perfusion on the correlation between cerebral stroke onset time and synthetic T2 mapping: a pilot study Qi Wang,Fei Bie,Tao Lu,Xuelian Sun,Qiang Sun,Gang Wang,Peiling Li	2023	4
8	Photothermal nanofibers enable macromolecule delivery in unstimulated human T cells Dominika Berdecka,Manon Minsart,Tao Lu,Deep Punj,Riet De Rycke,M Nikolić,Eduardo Bolea‐Fernandez,Frank Vanhaecke,Ranhua Xiong,Stefaan C. De Smedt,Peter Dubruel,Winnok H. De Vos,Kevin Braeckmans	2023	5
9	Review and prospects of targeted therapies for Spleen tyrosine kinase (SYK) Zhaozhao Wang,S. Qu,Jiahao Yuan,Wen Tian,Jinglei Xu,Rui Tao,Shilong Sun,Tao Lu,Weifang Tang,Yong Zhu	2023	8
10	Development of 3-acetylindole derivatives that selectively target BRPF1 as new inhibitors of receptor activator of NF-κB ligand (RANKL)-Induced osteoclastogenesis Wenqiang Zhang,Ruonan Ning,Ting Ran,Peng Qi,Yong Liu,Tao Lu,Yadong Chen,Min Jiang,Yu Jiao	2023	2
11	Discovery of N-(4-(3-isopropyl-2-methyl-2H-indazol-5-yl)pyrimidin-2-yl)-4-(4-methylpiperazin-1-yl)quinazolin-7-amine as a Novel, Potent, and Oral Cyclin-Dependent Kinase Inhibitor against Haematological Malignancies Jianhang Huang,Xinren Wang,Ruinan Dong,Xiaoyue Liu,Hongmei Li,Tianyi Zhang,Junyu Xu,Chenhe Liu,Yanmin Zhang,Shaohua Hou,Weifang Tang,Tao Lu,Yadong Chen	2021	12
12	Design and synthesis of dual inhibitors targeting snail and histone deacetylase for the treatment of solid tumour cancer Hao Cui,Jingkun Huang,Lei Yan,Quanwei Chen,Zan Hu,Jiaqi Niu,Ran Wei,Yang Kang,Hongmei Li,Tao Lu,Yong Zhu,Yatian Huang	2021	16
13	FLT3 Inhibitors in Acute Myeloid Leukemia: Challenges and Recent Developments in Overcoming Resistance Zhijie Wang,Jiongheng Cai,Jie Cheng,Wenqianzi Yang,Yifan Zhu,Hongmei Li,Tao Lu,Yadong Chen,Shuai Lü	2021	67
14	Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations Zhijie Wang,Jiongheng Cai,Jiwei Ren,Yun Chen,Yingli Wu,Jie Cheng,Kun Jia,Fei Huang,Zitian Cheng,Tiancheng Sheng,Shiyu Song,Hao Heng,Yifan Zhu,Weifang Tang,Hongmei Li,Tao Lu,Yadong Chen,Shuai Lü	2021	22
15	A potent CBP/p300-Snail interaction inhibitor suppresses tumor growth and metastasis in wild-type p53-expressing cancer Hongmei Li,Yan-Ran Bi,Li Yang,Rong Fu,Wencong Lv,Nan Jiang,Ying Xu,Bo‐Xue Ren,Yadong Chen,Hui Xie,Shui Wang,Tao Lu,Zhao‐Qiu Wu	2020	40
16	Investigation of Machine Intelligence in Compound Cell Activity Classification Yuanrong Fan,Yanmin Zhang,Yi Hua,Yuchen Wang,Lu Zhu,Junnan Zhao,Yang Yan,Xingye Chen,Shuai Lü,Tao Lu,Yadong Chen,Haichun Liu	2019	7
17	Combining structure- and property-based optimization to identify selective FLT3-ITD inhibitors with good antitumor efficacy in AML cell inoculated mouse xenograft model Hao Heng,Zhijie Wang,Hongmei Li,Yatian Huang,Qing-Yuan Lan,Xiao-Xing Guo,Liang Zhang,Yanle Zhi,Jiongheng Cai,Tianren Qin,Xiang Li,Shuxian Wang,Yadong Chen,Tao Lu,Shuai Lü	2019	13
18	Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation Hao Heng,Yanle Zhi,Haoliang Yuan,Zhijie Wang,Hongmei Li,Shuxian Wang,Jieyi Tian,Haichun Liu,Yadong Chen,Tao Lu,Ting Ran,Shuai Lü	2018	18
19	Discovery of 4-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((4-methylpiperazin-1-yl)methyl)phenyl)-1H-pyrazole-3-carboxamide (FN-1501), an FLT3- and CDK-Kinase Inhibitor with Potentially High Efficiency against Acute Myelocytic Leukemia Yue Wang,Yanle Zhi,Qiaomei Jin,Shuai Lü,Guowu Lin,Haoliang Yuan,Taotao Yang,Zhanwei Wang,Chao Yao,Jun Ling,Hao Guo,Tonghui Li,Jianlin Jin,Baoquan Li,Li Zhang,Yadong Chen,Tao Lu	2018	89
20	First detection of Tuala-like Hantanvirus from Eothenomys milelus in China. Jinglin Wang,Hailin Zhang,Jihua Zhou,Weihong Yang,Yuzhen Zhang,Mi ZhuQing,Luo DeRong,Yang Li-gui,Yang Jiao,Zhao WuSheng,Zhang PingYuan,Huachang Li,Wei Li,Tao Lu,Xiliang Zhang	2010	1

About Tao Lu

Tao Lu is a scholar working on Computational Theory and Mathematics, Oncology and Hepatology, having authored 116 papers that have together received 2.4k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (20 papers), Cancer-related Molecular Pathways (10 papers), Protein Degradation and Inhibitors (10 papers), Acute Myeloid Leukemia Research (9 papers), Synthesis and biological activity (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Liver physiology and pathology (5 papers). The work is most often cited by research in Hematology (207 citations), Aging (29 citations) and Oncology (426 citations). Tao Lu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yadong Chen, Xuanyong Liu, Congqin Ning, Paul K. Chu, Hongmei Li, Shuai Lü, Honglu Wu, Jin Wen, Ye Zhang and Rong Fu.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact